• darkblurbgdarkblurbg
  • darkblurbg
  • darkblurbg
  • darkblurbg
  • darkblurbg
Center of BioModular Multi-Scale Systems
BioTech Startup School @KU

Health Education Building (HEB) Classroom 2110
2160 W 39th Ave Kansas City, KS 66160

Biotech Startup School 2019 will help you understand
more about the commercial potential of your work


What is Precision Medicine?

"Precision Medicine" is the term used for this transformative new model of healthcare that involves the selection of appropriate therapeutics tailored to a patient’s specific disease characteristics. Diagnostic tests are major enablers of Precision Medicine because they have the potential to identify changes in each individual patient's disease. The use of that knowledge can help to treat their disease through the development of treatment strategies to target specific molecular alterations unique to that patient. Ultimately, the goal of Precision Medicine is to improve patient outcomes.

A "Precision Medicine" initiative was announced by President Obama in his January 20th, 2016, State of the Union address. President Obama said he wanted the United States to "lead a new era of medicine, one that delivers the right treatment at the right time."

Rather than the current one-size-fits-all approach, drugs will be tailored to individuals, allowing doctors to target the precise form a disease takes in any individual and avoid administering drugs that may be ineffective or even harmful.

CBM2 is making timely and important discoveries to the Precision Medicine initiative by developing new and state-of-the-art tools that can transition quickly into the clinic to provide diagnostic and prognostic information currently inaccessible to the patient due to limitations in current testing platforms. CBM2 is generating diagnostic tools that will be able to detect rare disease-associated biomarkers in blood samples, such as Liquid Biopsy, and supply important information to the clinician to dramatically improve quality of care for that patient. This is being done for a variety of diseases, such as cancer, stroke and infectious diseases to name a few.

BenchToBedside: Detecting Undetectable Cancers

Themed collection on bioanalytical tools for enabling precision medicine
Guest Editors
Steven Soper
U Kansas
Andrew Godwin
U Kansas
Cancer Center
  • Focus: bioanalytical tools for enabling precision medicine, including imaging, spectroscopy, machine learning, on both solid tumours and liquid biopsy samples
  • Submission deadline 31st May 2019
Register your interest:
Expo 19

The University of Kansas School of Engineering Presents
the 2019 Expo: Creating the Future

Sunday, February 24th and Monday, February 25th.

Please join us for an exciting day of learning about engineering and science.

Email engrexpo@ku.edu with questions.

Precision Medicine



Our Mission

To design, manufacture and deliver new tools to the biomedical community for utilizing liquid biopsies for disease detection and management.



Our Vision

Innovative and fully automated mixed-scale systems that can be programmed to enable Precision Medicine in different disease states.